Which benefits and harms of preoperative radiotherapy should be addressed? A Delphi consensus study among rectal cancer patients and radiation oncologists

被引:16
作者
Kunneman, Marleen [1 ]
Pieterse, Arwen H. [1 ]
Stiggelbout, Anne M. [1 ]
Marijnen, Corrie A. M. [2 ]
机构
[1] Leiden Univ, Med Ctr, Dept Med Decis Making, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Clin Oncol, NL-2300 RC Leiden, Netherlands
关键词
Preoperative radiotherapy; Rectal cancer; Communication; Information provision; Shared decision making; Delphi-method; TOTAL MESORECTAL EXCISION; INFORMATION NEEDS; RISK-FACTORS; FOLLOW-UP; THERAPY; TRIAL; MULTICENTER;
D O I
10.1016/j.radonc.2014.11.034
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: We previously found considerable variation in information provision on preoperative radiotherapy (PRT) in rectal cancer. Our aims were to reach consensus among patients and oncologists on which benefits/harms of PRT should be addressed during the consultation, and to assess congruence with daily clinical practice. Materials and methods: A four-round Delphi-study was conducted with two expert panels: (1) 31 treated rectal cancer patients and (2) 35 radiation oncologists. Thirty-seven possible benefits/harms were shown. Participants indicated whether addressing the benefit/harm was (1) essential, (2) desired, (3) not necessary, or (4) to be avoided. Consensus was assumed when >= 80% of the panel agreed. Results were compared to 81 audio-taped consultations. Results: The panels reached consensus that six topics should be addressed in all patients (local control, survival, long term altered defecation pattern and faecal incontinence, perineal wound healing problems, advice to avoid pregnancy), three in male patients (erectile dysfunction, ejaculation disorder, infertility), and four in female patients (vaginal dryness, pain during intercourse, menopause, infertility). On average, less than half of these topics were addressed in daily clinical practice. Conclusions: This study showed substantial overlap between benefits/harms that patients and oncologists consider important to address during the consultation, and at the same time poor congruence with daily clinical practice. (C) 2014 The Authors. Published by Elsevier Ireland Ltd.
引用
收藏
页码:212 / 217
页数:6
相关论文
共 23 条
  • [1] Occurrence of second cancers in patients treated with radiotherapy for rectal cancer
    Birgisson, H
    Påhlman, L
    Gunnarsson, U
    Glimelius, B
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6126 - 6131
  • [2] Late adverse effects of radiation therapy for rectal cancer -: a systematic overview
    Birgisson, Helgi
    Pahlman, Lars
    Gunnarsson, Ulf
    Glimelius, Bengt
    [J]. ACTA ONCOLOGICA, 2007, 46 (04) : 504 - 516
  • [3] Burbach JP, 2014, RADIOTHER ONCOL
  • [4] Comprehensive Cancer Centre The Netherlands, 2014, GUID MAN COL CANC CO
  • [5] Evaluating patient education materials about radiation therapy
    Dunn, J
    Steginga, SK
    Rose, P
    Scott, J
    Allison, R
    [J]. PATIENT EDUCATION AND COUNSELING, 2004, 52 (03) : 325 - 332
  • [6] Preoperative intensity-modulated and image-guided radiotherapy with a simultaneous integrated boost in locally advanced rectal cancer: Report on late toxicity and outcome
    Engels, Benedikt
    Platteaux, Nele
    Van den Begin, Robbe
    Gevaert, Thierry
    Sermeus, Alexandra
    Storme, Guy
    Verellen, Dirk
    De Ridder, Mark
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 110 (01) : 155 - 159
  • [7] A systematic overview of radiation therapy effects in rectal cancer
    Glimelius, B
    Grönberg, H
    Järhult, J
    Wallgren, A
    Cavallin-Ståhl, E
    [J]. ACTA ONCOLOGICA, 2003, 42 (5-6) : 476 - 492
  • [8] The Experience of Symptoms and Information Needs of Cancer Patients Undergoing Radiotherapy
    Guleser, Gulsum Nihal
    Tasci, Sultan
    Kaplan, Bunyamin
    [J]. JOURNAL OF CANCER EDUCATION, 2012, 27 (01) : 46 - 53
  • [9] Hack TF, 2005, PSYCHO-ONCOLOGY, V14, P831, DOI 10.1002/pon.949
  • [10] Holm T, 1996, CANCER, V78, P968, DOI 10.1002/(SICI)1097-0142(19960901)78:5<968::AID-CNCR5>3.3.CO